Search 1
Entities
LogoName Σ Employees
Laboratoire ClaripharmTM Laboratoire ClaripharmTM

Laboratoire Claripharm, women healthcare manufacturer Made in 🇫🇷 ClaripharmTM Laboratory has developed an innovative range of products for the care and protection of intimate wounds and sutures. ClaripharmTM created Claricare TM : the first flexible shell for protection of intimate wounds & stitches after a perineal tear or an episiotomy, vulvar and anal galling or condyloma, bartholinitis, labiaplasty, vaginal prolapse, coccyx dislocation, hemorrhoids, anal fissures, intimate cosmetic surgery ... Claricare TM is a patented medical device, CE marked and manufactured in France . ONCE UPON TIME A WOMAN... Giving birth to a child is one of the most intense and …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

103 6 92 14
BrainXchange BrainXchange

Your source for all things enterprise metaverse. BrainXchange is a world-class conference organizer and thought leader in the enterprise AR/VR/MR (XR), Metaverse, and emerging technology space. B2B Events, Augmented Reality, Virtual Reality, Wearable Technology, Industrial Technology, Tech Expo, Content Marketing, Mixed Reality, Exoskeletons, Internet of Things (IoT), Enterprise Mobility, Emerging Technology, and Metaverse

Type: Startup Activities: IT Services Technologies: IoT Synthetic Biology VR

86 0 86 8
Generis Generis

Tomorrow's Connection Today GENERIS IS A FULL-SERVICE ORGANIZER OF WORLD CLASS BUSINESS SUMMITS We provide leading industry insight, innovative onsite technical and strategic expertise through a platform uniquely designed for executives and professionals to connect. Our experience spans across two decades in successfully developing and delivering high-quality business to business events and services across various industries. Generis was formed with the vision of redefining the way in which knowledge transfer and face to face interactions take place. We see an opportunity to enhance the partnership experience through our understanding of how executives and professionals create and sustain successful relationships. Our …

Type: Startup Activities: healthtech spacetech deeptech biotech transporttech Technologies: Synthetic Biology

73 1 44 120
ErgoSanté ErgoSanté

ERGONOMICS FOR ALL ErgoSanté is a company specialized in the design, manufacturing, and distribution of customized ergonomic solutions aimed at maintaining employment for workers with disabilities and preventing musculoskeletal disorders (MSDs) risks. ErgoSanté distributes its products both nationally and worldwide. Our approach is unique: once your needs have been identified by healthcare professionals (such as occupational physicians, ergonomists, or employment support advisors), we lend you the recommended equipment for free so that you can judge the effectiveness of the proposed solution for yourself. We cater to both seated employees (with ergonomic chairs, height-adjustable desks, and accessories) and standing employees (with …

Type: Startup Activities: healthtech manufacturing Technologies: Synthetic Biology

48 3 43 150
Qubit Pharmaceuticals Qubit Pharmaceuticals

Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Drug Discover, Computational Chemistry, Molecular Dynamics Simulation, and Quantum Physics

Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

46 17 36 59
LATTICE MEDICAL LATTICE MEDICAL

Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue regeneration. Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue regeneration using biomaterials. With the aim of providing patients with a better quality of care, Lattice Medical has developed two devices: MATTISSE, a 3D-printed resorbable breast implant, and RODIN, a matrix for regenerating the hypodermis. implant, breast reconstruction, aesthetics, tissue engineering, textile, biomaterials, 3D printing, breast cancer, Medical Devices, and filament for 3D printing

Tags: FrenchTech2030 Type: Startup Activities: deeptech healthtech manufacturing Technologies: 3D Printing Synthetic Biology

40 13 34 24
Peptone Peptone

Bringing order to disorder We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins

Type: Startup Activities: biotech deeptech IT Services Technologies: Synthetic Biology

31 2 32 48
altizem altizem

[Automatic translation follows] I like it 😊 🔹 We are an operational consulting company specializing in the Life Sciences sector (pharmaceutical, agri-food, medical devices, cosmetics and fine chemicals) of the MoOngy Group. We support our clients (Sanofi, Merck, Nestlé, LVMH, etc.) throughout the entire life cycle of a product, by mobilizing our engineering and pharmacist consultants. 🚀 Altizem represents annual growth of +35%, a presence throughout France and strong values ​​built around people. 🏆 We are ChooseMyCompany HappyAtWork and ImpactIndex 2022 certified. MoOngy is Ecovadis Gold accredited 🏆 🔥 Passion, Proximity, Performance & Commitment are the values ​​to which each …

Type: SMB Activities: HRtech Technologies: Synthetic Biology

32 0 32 147
Gravipack® Gravipack®

[Automatic translation follows] The backpack that takes the strain off your shoulders. The weight is distributed over the center of gravity of the body. I created an extraordinary innovation: an exoskeleton that lightens the load on the shoulders and back. Discover GRAVIPACK, the ultimate solution to solve the major problem of pressure on the shoulders, thorax and arms. GRAVIPACK is the only shoulder strap system in the world that distributes weight across the human body's center of gravity, providing a feeling of lightness and combating musculoskeletal disorders (MSD). 🔝🩺IMPROVED HEALTH Frees the natural movement of the arms. Maintain an upright …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

33 1 32 4
Apodis Apodis

[Automatic translation follows] Connects medicine stakeholders around the patient #GoodUsage #PatientEmpowerment #RuptureMédicaments #eHealth #IA Apodis is the mobile and web application that connects drug stakeholders around the patient to support them in the proper use and compliance with their treatment. Our vision: transform access to care by allowing the patient to become an actor in their daily health Apodis addresses two major issues for patients and our healthcare system: - Drug shortages which have continued to increase for 20 years - The misuse of medications which leads to more than 1 million days of hospitalization per year in France Concretely, …

Type: NGO, Think-tanks, Ed, & Culture SMB Activities: healthtech Technologies: Synthetic Biology

26 6 31 17
Continuum Plus Santé Continuum Plus Santé

[Automatic translation follows] Reinventing the monitoring of patients on cancer drugs #AKOadom, Continuum+ Connect Remote Monitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and remote monitoring

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

32 3 28 17
WhiteLab Genomics WhiteLab Genomics

AI/ML for Genomic Therapies We are specialised in AI solutions for advanced therapies such as gene and cell therapies.

Tags: FrenchTech2030 Type: Startup Activities: deeptech IT Services Technologies: A.I. A.I. - Machine Learning Synthetic Biology

38 15 28 38
Cilcare Cilcare

MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

32 10 27 33
IFPMA IFPMA

We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

33 12 25 69
NovAliX NovAliX

NovAliX is a preclinical drug discovery-focused CRO NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

27 4 25 379
TreeFrog Therapeutics TreeFrog Therapeutics

Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological …

Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

34 13 25 133
HAPPLYZ Medical - LORIO, respiratory rehabilitation 🎮 HAPPLYZ Medical - LORIO, respiratory rehabilitation 🎮

Breathe&Play, the new playful way to rehabilitate your respiratory system 🚀 Patented solution #videogames #medtech Step into the world of connected healthcare ! 394 millions people suffering from chronic respiratory diseases. Less than 10% of them regularly engage in respiratory rehabilitation, primarily due to lack of motivation. We have developed our first medical device from A to Z, LORIO, dedicated to monitored and gamified respiratory rehabilitation. LORIO is available in different versions for various purposes: at home, in medical practices, or collectively in rehabilitation centers. LORIO is a digital solution designed to improve the breathing capacity of these patients in …

Type: Startup Activities: deeptech Games healthtech manufacturing Technologies: Synthetic Biology

32 13 24 6
Arterya Arterya

The experts in the detection of the artery Normandy start-up based in Caen, we develop Blood'Up, a medical device that allows the instant detection of arteries.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

26 10 23 17
NETRI NETRI

INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

28 9 23 39
INDIENOV INDIENOV

[Automatic translation follows] Innovate to protect INDIENOV (commercial brand of HIPPY MS) designs and develops medical devices based on built-in electronics and artificial intelligence in order to extend the quality of life and independence of elderly people. INDIENOV (commercial brand of HIPPY MS) is an innovative company combining people and digital to save lives and serve better living. Its purpose, as a company with a mission, is to contribute to the independence and promote the autonomy of people at risk by innovating by all means. We act in this way to improve the safety, serenity and existence of people at …

Type: Startup Activities: healthtech manufacturing Technologies: Synthetic Biology

29 9 23 18
CorWave CorWave

CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up …

Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech manufacturing nanotech Technologies: Synthetic Biology

24 10 22 91
DNA Script DNA Script

Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology

Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

31 12 22 205
Myotact Myotact

Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

23 5 22 1
Catsalyze Catsalyze

We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze.

Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology

25 4 22 2
FineHeart FineHeart

A Healthier Life With Every Beat FineHeart is a clinical stage medical device company based in Bordeaux, France. Its innovative product, FLOWMAKER®, has the potential to treat 200,000 patients with advanced heart failure each year. FineHeart will initially target the 50,000 most severe patients who are eligible for cardiac assistance. Initial estimates value this market segment to be worth over US$5 billion. FineHeart was founded by CEO Arnaud Mascarell and a team of internationally renowned cardiac surgeons and electro-physiologists, including Dr. Stephane Garrigue, CSO and inventor of the concept, and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy (CRT). The …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

25 6 21 71
MaaT Pharma MaaT Pharma

The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

25 8 21 76
Kiro Kiro

Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical …

Tags: FrenchTech2030 Type: Startup Activities: healthtech biotech Technologies: A.I. Synthetic Biology

31 10 21 43
GTP Bioways GTP Bioways

Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

21 5 20 135
Resilience Resilience

[Automatic translation follows] Better treatment of cancer thanks to digital technology Resilience is a company dedicated to remote monitoring and support for oncology patients whose mission is to better treat cancer. Through synergistic tools intended for patients and those who care for them, Resilience provides a global solution aimed at humanizing, streamlining and personalizing care pathways. The Resilience mobile application supports people affected by cancer on a daily basis to help them cope better with the side effects caused by their treatments and improve their quality of life. The Resilience remote monitoring platform, a class IIa medical device, allows healthcare …

Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

37 25 20 155
Umiami Umiami

The next generation of plant-based meat. Tasty, Tender, and Sustainable whole-cuts. Umiami is a French foodtech that was founded in 2020 with the mission to reduce worldwide meat consumption and its impact on health, animals, and the environment. We are pioneers in the development of a patent-pending process for texturizing plant proteins called "umisation". With our umisation technology, we can recreate the meat and fish fillet experience without compromising on taste and texture. After opening our first pilot plant innovation center last year, Umiami will inaugurate its first large-scale production plant in October 2023. The 14,000m2 site is located in …

Tags: FrenchTech2030 Type: Startup Activities: foodtech manufacturing Technologies: Synthetic Biology

34 19 20 105
Wandercraft Wandercraft

Ordinary life for Extraordinary people We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US. Atalante is not only an exoskeleton. Atalante allows patients to stand up, without crutches. Atalante allows patients to finally be able …

Tags: FrenchTech2030 Type: Startup Activities: deeptech healthtech Technologies: Robotics Synthetic Biology

37 17 19 125
Institut Carnot CALYM Institut Carnot CALYM

Consortium dedicated to partnership-based research on lymphomas CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere. CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research: 2 non-profit associations: – The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of …

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: deeptech Technologies: Synthetic Biology

19 1 19 21
Predilife Predilife

Prédire pour prévenir - Bilans prédictifs permettant d'identifier le risque de maladies graves Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional. After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments. At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people. We accompany companies, healthcare professionals and employees …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

20 3 18 34
Defymed Defymed

Advanced therapies inspired for you Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century. There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase: - #MailPan®: bioartificial …

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

18 0 18 4
Perfect Day Perfect Day

Complete whey protein, made more sustainably. We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some …

Type: Startup Activities: agritech biotech deeptech foodtech Technologies: Synthetic Biology

21 2 18 327
Nanobiose Nanobiose

Smart tools for cell biology Nanobiose’s mission is to provide pharma, biotech and cosmetic companies with better tools to improve their in vitro analysis of efficacy / safety of drug candidates. Nanobiose develops SecretCells®, an innovative lab-on-a-chip system to evaluate secreted biomarkers from 2D or 3D perfused cells. SecretCells® combines a microfluidic biochip (where the perfused 3D cell cultures stand) and a removable biosensor for a multiplexed on-line biomarkers analysis. While better mimicking in vivo like conditions, SecretCells® allows more accurate and more predictive results for the evaluation of drug candidates at early stages. SecretCells® is a very flexible solution …

Type: Startup Activities: biotech deeptech Technologies: Sensors Synthetic Biology

18 0 18 4
ImCheck Therapeutics ImCheck Therapeutics

Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune …

Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

28 13 18 51
Aenitis Technologies Aenitis Technologies

Acoustic Cell Processing Solution Aenitis develops and promotes devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focuses on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation. Sorting, acoustophoresis, medical devices, cells, and Bioproduction

Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

19 3 17 15
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News

The Bedrock of Biotech Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

21 3 17 265
HMT HMT

[Automatic translation follows] Work different - Work differently HMT supports all organizations of all sizes in their prevention approach to improve working conditions and limit the risks of the appearance of occupational diseases (MSD, RPS, etc.). Based on an ergonomic approach, our multidisciplinary team helps you identify, propose and integrate technical and organizational solutions that meet your projects. Our design office can also co-design and manufacture, in Tarbes, technical solutions specific to your activities. Mechanics, IT, Electronics, Handling, Exoskeleton, Design, Production, Study, and Ergonomics

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

17 0 17 37
The Science Advisory Board The Science Advisory Board

The source of discovery and development in the life sciences. The Science Advisory Board is a global community of scientists and medical professionals from around the world. Manufacturers of laboratory instruments and consumables, pharmaceutical and medical device companies, financial institutions and government agencies rely on the perspectives of our members when making important decisions. life science, molecular biology, cell biology, molecular diagnostics, drug discovery, bioprocessing, clinical chemistry, microbiology, proteomics, genomics, gene therapy, immunology, medicinal chemistry, stem cell biology, pathology, and analytical chemistry

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

17 0 17 11
BioProcess International BioProcess International

brought to you by Informa Connect BioProcess InternationalTM is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process. BPI is a business unit of Informa Connect https://informaconnect.com marketing, Biopharmaceutical, biotechnology, print, electronic, online, advertising programs, bioprocessing, vaccines, monoclonal antibodies, protein therapeutics, cell therapies, gene therapy, cell therapy, and biomanufacturing

Type: SMB Activities: biotech deeptech martech Technologies: Synthetic Biology

16 1 16 18
AQEMIA AQEMIA

Scale Drug Discovery with Quantum-inspired Physics and AI Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates. We are hiring! Check our career website: https://jobs.lever.co/aqemia.com Blog Posts on: https://medium.com/aqemia drug discovery, in silico drug discovery, Pharmaceutical R&D, Artificial intelligence, HPC developer, drug hunting, software developer, quantum, and drug design

Tags: FrenchTech2030 Type: Startup Activities: deeptech healthtech Technologies: A.I. Generative A.I. Synthetic Biology

28 17 16 59
ZMF RESOURCES SASU ZMF RESOURCES SASU

Consulting services in Clinical Research and WEB /WEB app Development. Your Project, Our Mission! ZMF RESOURCES is a an independent consulting company under the directorship of Zoé Moksi. We provide consulting services in Clinical Research and IT/Web to help organizations execute their critical business initiatives: 1-Clinical Research consulting services : Project Management, Regulatory Affairs, Investigation Sites Management & Monitoring, Medical Writing, eCRF design and development, Quality Assurance (Inspection readiness, Audits, SOPs development and review...), Quality Check monitoring visits, Vendors oversights, Budget set-up and oversight, Local expertise & Legal representative, Management of Patient Travel Expenses Reimbursement and Sites Contracts, etc. Our …

Type: SMB Activities: IT Services Technologies: Synthetic Biology

16 1 16 3
MOTEN Technologies MOTEN Technologies

Preventing risks of MSD by measuring muscular effort. MOTEN Technologies is a startup founded in 2018 and centered around a mission : to preserve the health and performance of men and women whose muscles constitute a precious and irreplaceable capital. After a year of development, we have prototyped and manufactured in France the first measurement technology «listening» the sounds produced by the muscles, revealing their level of effort and fatigue in any situation. Today, we support companies in various sectors whose operators are exposed to the risks of occupational diseases and accidents related to physical activity. Our clients seek to …

Type: Startup Activities: IT Services Technologies: Synthetic Biology

22 5 16 11
Horus Pharma Horus Pharma

Horus Pharma is an independent French laboratory specialised in ophthalmology. Founded in 2003, Horus Pharma develops, patents and markets products designed to facilitate eye and eyelid health. Horus Pharma operates in most segments related to ophthalmology and develops practical innovations that combine efficacy and safety. Read our community guidelines https://bit.ly/HPCommunityGuidelines Focused on patient safety, our laboratory has developed recognised expertise in the development of preservative-free formulations and product delivery systems. The product portfolio at the laboratory includes medicinal products, medical devices and food supplements. With its new Surgery Division, Horus Pharma is pursuing its growth by offering surgical and peri-surgical …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

18 3 16 243
Diabeloop Diabeloop

Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡ We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

33 16 15 125
The Medicine Maker The Medicine Maker

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

17 2 15 3
Rabin Martin Rabin Martin

Together, we can make a lasting impact on global health – and your business. We’re Rabin Martin, a team of global health impact consultants. Driving better outcomes, access and equity – from strategy to execution. ​ We design, develop and deliver effective solutions to unlock new markets and opportunities – creating creative ways for more people to access our client's medicines and vaccines, and generating support among key stakeholders. ​ In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth. To do this, we bring together …

Type: SMB Activities: Consulting Technologies: Synthetic Biology

16 1 15 48
Poly-Dtech Poly-Dtech

Enhance your detection Founded in 2019, Poly-Dtech is a French company, based in Strasbourg, specializing in innovative solutions for biomarker detection through an advanced cutting-edge technology: Bright-DtechTM 🎯 OUR MISSION: We aim to enhance current screening, drug discovery, and early disease diagnosis by advancing biomarker detection in scientific research and medical diagnostics. Poly-Dtech develops and produces immunoassays and Lateral Flow tests based on high-performance fluorescent nanoparticles with unique features. 🧪 BRIGHT-DTECHTM TECHNOLOGY: Bright-DtechTM represents a cutting-edge lanthanide-based fluorescent nanoparticles, surpassing existing products by significantly improving biomarker detection across diverse sample types and concentration levels, including previously undetected biomarkers. ⁃ User-friendly …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

16 6 15 7
ICARE* ICARE*

Icare : Expert dans la maîtrise de la sécurité des produits de santé Groupe ICARE : Votre partenaire expert de la sécurité des produits de santé Avec 30 ans d’expérience, le Groupe ICARE se distingue comme un leader en matière de normalisation et de réglementation internationale. Nous guidons les acteurs du secteur de la santé à travers le complexe paysage réglementaire, assurant que chaque dispositif et produit de santé est commercialisé en toute conformité et sécurité. Notre expertise couvre un large éventail de services essentiels pour garantir l’excellence et la conformité de vos produits : • Biocompatibilité et Toxicologie : …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

16 4 15 201
Redberry SAS Redberry SAS

Industrial microbiology testing providing immediate results at performance and ease-of-use never reached before. Redberry develops a new platform aimed at avoiding the culture phase of microorganisms in industrial microbiology and thus providing immediate results at cost, performance and ease-of-use never reached before. Microbiology and Diagnostics

Type: Startup Activities: deeptech Technologies: Synthetic Biology

18 8 15 14
Nextep Health Nextep Health

Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” …

Type: SMB Activities: Consulting healthtech govtech Technologies: Synthetic Biology

17 3 14 51
Insilico Medicine Insilico Medicine

#insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, …

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology

17 1 14 269
Yuri Yuri

Space biotech for a better life 🧫🚀 yuri is a space biotech company that uses the microgravity environment of space to develop and manufacture superior biotech products. The team of 30+ space engineers and biologists has worked on 20+ payloads for the International Space Station in collaboration with organizations like NASA, ESA, GSK, Charité Berlin. We develop modular bioreactors and incubators for cell cultures, protein crystals or plants and launch them for scientists around the world to the ISS and other spacecraft such as Sierra Nevada Dream Chaser or SpaceX Dragon. We also sell and rent devices to simulate microgravity …

Type: Startup Activities: manufacturing spacetech Technologies: Synthetic Biology

15 1 14 37
Maya AI Maya AI

Meet Maya AI, a generative AI platform that provides real-time actionable insights from internal and external data ☁️🤖 At Maya AI, we are passionate about helping enterprise companies understand their data journey by finding answers with more access, speed, and discovery. Maya AI is a generative AI platform that provides actionable insights from internal and new data in real-time. We are designed to help retail, finance, healthcare, pharmacy, technology, and other areas to help make more informed decisions by uncovering valuable insights from their data. Learn more: https://mayaknows.com AI Systems, Machine Learning, Internet of Things, GenerativeAi, Drug Discovery, Patient data …

Type: Startup Activities: IT Services Technologies: A.I. Data Analytics A.I. - Deep Learning A.I. - Natural Language Processing A.I. - Machine Learning Synthetic Biology Generative A.I.

15 1 14 12
Pixacare Pixacare

Turning smartphones into powerful medical devices 📲 Medical photo management, Wound management, Artificial intelligence "Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

21 7 14 22
Carthera Carthera

Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

24 11 13 27
Archeon Medical Archeon Medical

High-Performance artificial ventilation for the EMS, Hospitals and military organizations. Archeon takes its name from the Acheron river, a tributary of the legendary Styx, which separates the world of the living from Hades, the greek mythological world of the dead. We are a french company made up of people who believe in innovation and in the great opportunities offered by deep technology and artificial intelligence to save lives. Patient Monitoring & Diagnostics, Emergency Care, Critical care devices, Medical devices, Basic & Advanced Life Support, and Cardiopulmonary Resuscitation

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

15 3 13 24
Ludocare Ludocare

Evidence-based digital therapies that improve adherence and overall health of children with chronic conditions. Created in 2017 in Lyon, Ludocare develops evidence-based digital therapies for the benefit of patients, those around them and healthcare professionals. ✅ Its objective: better control of the disease and stabilization of basic treatment, to improve the quality of life of children with chronic illnesses. 💡The medical purpose of JOE digital therapy is to improve asthma control through better use of inhalation devices and increased compliance with drug treatments, and thus preventively reduce attacks and exacerbations. ➡️ To date, Ludocare is part of a scientific approach …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

15 8 13 7
CENTOGENE CENTOGENE

The essential biodata life science partner for rare and neurodegenerative diseases CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization. Biochemical diagnostic test, Genetic diagnostic test, Rare diseases, Congenital diseases, Oncogenetics, Clinical and medical interpretation of genetic data, Next Generation …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

17 0 13 440
Osivax Osivax

Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company …

Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

22 11 13 53
Okomera Okomera

Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

16 6 13 25
Aldebaran Aldebaran

[Automatic translation follows] Aldebaran is building the first digital medical assistant certified as a medical device for patients and practitioners. Aldebaran is developing an intelligent digital medical assistant for preparing consultations, guiding and optimizing the health pathway, prevention and medical decision support. Capable of adapting to any patient and any health need, our digital medical assistant allows healthcare professionals who receive consultations to free up medical time, better take care of their patients and increase the relevance of their care. Aldebaran differentiates itself from traditional e-health players by emphasizing the ethical, scientific and technological aspects (“Deep Tech” BPI label November …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

14 3 13 25
AIS BIOTECH AIS BIOTECH

Fight against emerging infectious diseases @AIS Biotech (with AIS for Anti Infective Sugar) is a French Biotech company based in the @Région Auvergne-Rhône-Alpes, France, incorporated in March 2023 with the objective of developing a new class of sugar-based anti-infective biotherapeutics to fight (re)emerging infectious diseases. Thanks to a Bioengineering plateform based on the expertise of the leading edge academic laboratory @CERMAV (@CNRS, @UGA, Grenoble, France), AIS Biotech aims to develop a pipeline of innovative sugar-based biopharmaceuticals which can prevent or treat infections by mimicking the natural host surface oligosaccharide binding-sites of pathogens. GlycoFlu, our first drug-candidate validated at the preclinical …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

17 6 13 5
MediSieve MediSieve

Novel Biotech dual-platform: therapeutic and drug-delivery MediSieve is a London biotech start-up developing Magnetic Haemofiltration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. A unique, lifesaving and often cost-saving solution, there are several multi-billion-dollar markets available for this product in oncology, infectious diseases, auto-immune diseases, poisoning, drug overdose and others. Magnetic Haemofiltration has already been shown to rapidly, specifically, and effectively remove IL-6 from human plasma. …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

12 1 12 14
BioMelbourne Network BioMelbourne Network

Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise …

Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

12 1 12 14
Spartha Medical Spartha Medical

the active interfaces We develop the first range of versatile and customisable active interfaces with sustainable formulations. We use supramolecular chemistry and biopolymers to produce the first-in-class protective kit, protect|ION, to help patients and medical staff with wound healing to fight antibiotic resistance and hospital-acquired infections. Our customised spartha|SHIELD service offering and its SHIELD+ extension enable innovative and safe products to be developed by integrating our technologies through codevelopment, in the medical device, cosmetics, electronics and textile sectors. Coatings, Antimicrobial, Medical Devices, Implants, Polymers, Biomaterials, Anti-inflammatory, Nanotechnology, and Personalised Medicine

Type: Startup Activities: deeptech healthtech manufacturing Technologies: New Materials Synthetic Biology

14 5 12 26
Tebubio Tebubio

Facilitators of Life Sciences Research Our vision of helping to advance Life Sciences research every day, is embodied by providing a unique, holistic range of solutions to make your life easier – simply and quickly accessible. The full scope of your needs is at the center of our attention. Our experts provide reliable, multimodal solutions, encompassing our extensive range of products, in-house laboratory platforms, and our practical administrative and logistics services. You’ll find the right combination of answers to accelerate your daily work – in one place. Every day, you’ll benefit from our distinctive solutions, from simplified ordering with personalized …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

13 2 12 82
BIOTEM First Class Antibodies & Immunoassays BIOTEM First Class Antibodies & Immunoassays

Your partner in immunotechnologies since 1980! Our commitment makes the difference! Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards. Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects. Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract. BIOTEM advantages: - Results guaranteed - An unparalleled traceability throughout your project - Optimal quality of your product …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

14 3 12 44
Healshape Healshape

A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products

Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology

19 17 12 20
Japet Medical Japet Medical

Medical technology for health at work. Japet Medical is a exoskeleton manufacturer and integrator. This European startup combines medical technologies, textile expertise and modern robotics to create devices that relieve everyday aches and pains. Its Japet.W+ exoskeleton is the only motorized exoskeleton that protects employees' backs in all their movements. Every day, Japet Medical's teams help companies successfully integrate exoskeletons to combat musculoskeletal disorders. Find us on : https://www.japet.eu/ Robotics, Healthcare, Exoskeleton, Rehabilitation, health at work, Wearable Medicine, exosquelette, TMS, prévention, robotique, SST, QVCT, and RQTH

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Robotics Synthetic Biology

24 10 12 36
Deep Branch Deep Branch

We use clean and renewable carbon and energy sources to create ingredients for a more sustainable food system. ​​Deep Branch uses clean and renewable carbon and energy to create ingredients for a more sustainable food system. With a customer-focused research and development pipeline, it can quickly deliver high-quality, next-generation bio-based products to meet society’s demand for food and feed sustainably. By collaborating with local providers of strategic raw materials, Deep Branch can identify the best sites that offer sustainable input supply while helping develop the local economy. The company’s proprietary (R)evolveTM gas fermentation platform also uses sustainable and scalable feedstocks, …

Type: Startup Activities: cleantech greentech Technologies: Bio sourced materials Decarbonization Synthetic Biology

16 1 12 29
Dompé Dompé

We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

12 1 12 843
SeaBeLife Biotech SeaBeLife Biotech

Solutions to deprogram cell death : A breakthrough innovation to treat and prevent severe pathologies We develop small molecules that inhibit regulated necrosis using an original mechanism of action. Regulated necrosis is one of the recently identified pathophysiological factors in many diseases with severe outcomes. The technical, therapeutic and economic potential is major. Our activity focuses on the development of drugs inhibiting regulated necrosis, from the selection of the molecule to the proof of efficacy in the patient. We focus on acute and orphan diseases because preclinical and clinical development is facilitated, allowing proof of concept (POC) to be provided …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

14 4 12 15
SmartCatch SmartCatch

For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

15 5 12 21
Orakl Oncology Orakl Oncology

Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics

17 8 12 10
METAFORA biosystems METAFORA biosystems

AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, and research

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

15 2 12 34
STH BIOTECH STH BIOTECH

Unlocking the access to innovative ingredients and APIs from cannabis, thanks to plant biotechnology. STH BIOTECH develops unique and reliable plant-biotech process to produce cannabinoids at high yield & low cost.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

13 4 12 10
Relax "Diffuseur de bonne humeur" Relax "Diffuseur de bonne humeur"

[Automatic translation follows] Relax “Good mood diffuser”® an alternative to medication in the management of stress and anxiety. RELAX, the result of a collaboration with experts in interventional cardiology, was developed to meet the needs of medical services. This innovative therapeutic reality solution aims to alleviate the stress and anxiety associated with anxiety-provoking situations, including medical care and procedures. Designed with 2D relaxation glasses, RELAX technology offers an approach without side effects, suitable for a wide audience. These glasses can be used preventatively before a medical procedure, during the procedure to ease patient anxiety, and afterward to aid emotional recovery. …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

14 3 12 6
Hilum Healthcare Hilum Healthcare

Not your grandpa's Medtech The story of aerospace engineers who aim at building top-notch medical devices.

Type: Startup Activities: healthtech Technologies: Synthetic Biology

14 0 12 9
SYNTHELIS SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

12 3 11 7
GenSight Biologics GenSight Biologics

Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

13 2 11 41
Cyclica (acquired by Recursion, Nasdaq: RXRX) Cyclica (acquired by Recursion, Nasdaq: RXRX)

From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. A.I. - Machine Learning

15 2 11 8
EVEON EVEON

Transforming Patient Experience EVEON aims to become international leader in the automatic preparation and delivery of therapeutic treatments to improve patient quality of life. As a partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation products and services. Forward looking, EVEON places at the heart of its commitments social values of high standards that meet the challenges of personalized and participative medicine. EVEON focuses on business partnerships with a collaborative spirit of transparency and openness. EVEON develops a strategy based on ethical values of performance and adaptability to the needs of its clients.

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

13 3 11 22
Innate Pharma Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

18 7 11 202
Cardiawave Cardiawave

Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis. Innovation prize winner of many contests, Cardiawave is a clinical-stage company which develops an innovative non-invasive image-guided medical device (MD) to treat aortic valve stenosis with ultrasound technology. Aortic stenosis is a life-threatening disease which is a major public health concern in Western countries (10 million people affected). The MD uses focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. The company was created at the end of 2014 as a result of a long-term partnership between the Langevin Institute / Physics for Medicine Paris, …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

20 12 11 36
Abolis Biotechnologies Abolis Biotechnologies

Decipher - Innovate - Build Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

11 1 11 42
CTIBiotech CTIBiotech

Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come …

Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

14 2 11 20
insitro insitro

Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale. insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach …

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

15 1 11 284
REGEnLIFE REGEnLIFE

Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, …

Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

13 2 11 12
Genomics plc Genomics plc

Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for all the common diseases and cancers, well ahead of …

Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

11 4 11 129
ORTHOPUS ORTHOPUS

Handitech solutions for everyone ORTHOPUS is a high-impact start-up that designs innovative and accessible robotic assistants for people with motor disabilities. Founded by David Gouaillier, co-creator of the NAO robot, ORTHOPUS is at the crossroads of technology and solidarity. The company has been awarded the "Entreprise solidaire d'utilité sociale" label, and its aim is to democratise access to assistive technologies. The team of robotics engineers is developing a range of exoskeletons and robotic arms dedicated to arm mobility. Open source hardware, humanitaire, fabrication numérique, prosthetics, and frugal innovation

Type: Startup Activities: IT Services manufacturing Technologies: Robotics Synthetic Biology

17 8 11 19
ExpertsMedTech, Alliance d'experts en santé ExpertsMedTech, Alliance d'experts en santé

[Automatic translation follows] The .EMT Alliance supports healthcare professionals from birth to the success of their projects. The .EMT alliance, a union of recognized players in HealthTech, supports professionals in the world of Health from project creation to marketing. We are involved in all phases of development and you centralize your actions within the same team of experts in Medtech, Biotech, Pharma, HealthTech. We created : TALKS! by .emt: 1 annual event dedicated to players in the world of Health with round tables on current themes, keynotes, individual meetings and networking. RISE! with .emt: 2 days of training dedicated to …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

11 1 11 2
NORAKER NORAKER

[Automatic translation follows] Bioglass Solutions for Bone Regeneration NORAKER, a French player in regenerative medicine,'s mission is to promote the reconstruction of the bones of patients who have undergone orthopedic or dental surgery. A spin-off from INSA Lyon in 2005, NORAKER innovates with its mastery of a biomaterial with exceptional properties: bioactive glass. NORAKER has been distributing its implants since 2015, with an international presence in more than 40 countries. The company invests in close and regular collaboration with surgeons and healthcare professionals, to always better meet the requirements of the medical environment. NORAKER products find their application in orthopedic, …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

13 5 11 37
Institut Rafaël Santé Intégrative Institut Rafaël Santé Intégrative

[Automatic translation follows] From diagnosis, act on global health #InstitutRafaël Integrative Health "It's time to write the health of tomorrow! The Rafaël Integrative Health Institute is a project of general interest for adapted and personalized support for patients affected by chronic diseases." Supportive care, nutrition, sports therapeutic education, psychologist, oncoesthetics

Type: Startup Activities: healthtech Technologies: Synthetic Biology

14 2 11 54
CLEAN BIOLOGICS CLEAN BIOLOGICS

Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance

Type: Startup Activities: deeptech Technologies: Synthetic Biology

13 7 11 11
Smart Immune Smart Immune

Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

21 12 11 40
Elektronik medical Elektronik medical

[Automatic translation follows] Innovative products and solutions for medical technology Far beyond product reporting, Elektronik medical offers developers, designers and management valuable specialist knowledge about medical technology and medical device development. Medical technology and technology

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

11 0 11 N/A
BigHat Biosciences BigHat Biosciences

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, ‍Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids …

Type: Startup Activities: biotech deeptech IT Services Technologies: A.I. Synthetic Biology SaaS Generative A.I.

11 0 11 91